Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase...

by Jin, S.‐M., Park, C.‐Y., Cho, Y. M., Ku, B. J., Ahn, C. W., Cha, B.‐S., Min, K. W., Sung, Y. A., Baik, S. H., Lee, K. W., Yoon, K.‐H., Lee, M.‐K., Park, S. W.
Published 2015

Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase‐4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24‐week multicentre, randomized, double‐blind, p...

by Hong, S., Park, C.‐Y., Han, K. A., Chung, C. H., Ku, B. J., Jang, H. C., Ahn, C. W., Lee, M.‐K., Moon, M. K., Son, H. S., Lee, C. B., Cho, Y.‐W., Park, S.‐W.
Published 2016

Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study

by Ryu, S Y, Kim, M H, Nam, B H, Lee, T S, Song, E S, Park, C Y, Kim, J W, Kim, Y B, Ryu, H S, Park, S Y, Kim, K T, Cho, C H, Lee, C, Kim, S M, Kim, B G, Bae, D S, Kim, Y T, Nam, J-H
Published 2014